𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma,results of a phase II single center study

✍ Scribed by Hannes Müller-Beißenhirtz; Christoph Kasper; Holger Nückel; Ulrich Dührsen

Publisher
Springer
Year
2005
Tongue
English
Weight
85 KB
Volume
84
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter phase 2 study of risk-adju
A multicenter phase 2 study of risk-adjusted salvage chemotherapy incorporating vinorelbine and gemcitabine for relapsed and refractory lymphoma
✍ Sant-Rayn Pasricha; Andrew Grigg; John Catalano; Michael Leahy; Craig Underhill; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

## Abstract ## BACKGROUND. Administration of salvage chemotherapy to patients with relapsed or refractory lymphoma is associated with significant toxicity. Vinorelbine and gemcitabine are novel chemotherapeutic agents with minimal overlapping toxicity. We present a phase 2 study of vinorelbine and

Phase II study of arsenic trioxide and a
Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study
✍ JE Chang; PM Voorhees; JM Kolesar; HG Ahuja; FA Sanchez; GA Rodriguez; K Kim; J 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

Arsenic trioxide (As 2 O 3 ) has established clinical activity in acute promyelocytic leukaemia and has pre-clinical data suggesting activity in lymphoid malignancies. Cell death from As 2 O 3 may be the result of oxidative stress. Agents which deplete intracellular glutathione, such as ascorbic aci